<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
	<title>ThaiPR.NET</title>
	<atom:link href="https://www.thaipr.net/tag/novo-nordisk-pharma-thailand/feed" rel="self" type="application/rss+xml" />
	<link>https://www.thaipr.net/tag/novo-nordisk-pharma-thailand</link>
	<description>Press Release Distribution Center of Thailand</description>
	<lastBuildDate>Wed, 07 Oct 2026 17:39:35 +0700</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title><![CDATA[Novo launches a new treatment option in Thailand for adults living with type 2 diabetes — offering holistic care beyond blood sugar control]]></title>
		<link>https://www.thaipr.net/en/health_en/3766754</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Wed, 07 Oct 2026 15:04:20 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/?p=3766754</guid>

					<description><![CDATA[<p>Novo Nordisk Pharma (Thailand) Ltd. (“Novo”) reaffirmed its long-standing commitment to people living with type 2 diabetes in Thailand, calling for greater public understanding of the disease as a serious, progressive condition that affects far more than blood sugar alone. The renewed call for awareness coincides with the local introduction of a higher dose semaglutide [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3766754">Novo launches a new treatment option in Thailand for adults living with type 2 diabetes — offering holistic care beyond blood sugar control</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
	</channel>
</rss>
